Home
Reels
Grupos
Páginas
Más
Grupos Páginas Eventos Blogs Financiamiento
Iniciar sesión Registrarse
Night Mode
How Are Anti-VEGF Therapies Shaping the Choroidal Neovascularization Market?
Anti-VEGF therapies are the cornerstone of the choroidal neovascularization market. Drugs that inhibit vascular endothelial growth factor reduce abnormal blood vessel growth and leakage, preserving vision in patients with CNV. Since their introduction, these therapies have transformed treatment and expanded the market. In the choroidal neovascularization market, competition among anti-VEGF...
0 Commentarios ·0 Acciones ·124 Views ·0 Vista previa
Please log in to like, share and comment!